Chidharla, A.; Rapoport, E.; Agarwal, K.; Madala, S.; Linares, B.; Sun, W.; Chakrabarti, S.; Kasi, A.
Circulating Tumor DNA as a Minimal Residual Disease Assessment and Recurrence Risk in Patients Undergoing Curative-Intent Resection with or without Adjuvant Chemotherapy in Colorectal Cancer: A Systematic Review and Meta-Analysis. Int. J. Mol. Sci. 2023, 24, 10230.
https://doi.org/10.3390/ijms241210230
AMA Style
Chidharla A, Rapoport E, Agarwal K, Madala S, Linares B, Sun W, Chakrabarti S, Kasi A.
Circulating Tumor DNA as a Minimal Residual Disease Assessment and Recurrence Risk in Patients Undergoing Curative-Intent Resection with or without Adjuvant Chemotherapy in Colorectal Cancer: A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences. 2023; 24(12):10230.
https://doi.org/10.3390/ijms241210230
Chicago/Turabian Style
Chidharla, Anusha, Eliot Rapoport, Kriti Agarwal, Samragnyi Madala, Brenda Linares, Weijing Sun, Sakti Chakrabarti, and Anup Kasi.
2023. "Circulating Tumor DNA as a Minimal Residual Disease Assessment and Recurrence Risk in Patients Undergoing Curative-Intent Resection with or without Adjuvant Chemotherapy in Colorectal Cancer: A Systematic Review and Meta-Analysis" International Journal of Molecular Sciences 24, no. 12: 10230.
https://doi.org/10.3390/ijms241210230
APA Style
Chidharla, A., Rapoport, E., Agarwal, K., Madala, S., Linares, B., Sun, W., Chakrabarti, S., & Kasi, A.
(2023). Circulating Tumor DNA as a Minimal Residual Disease Assessment and Recurrence Risk in Patients Undergoing Curative-Intent Resection with or without Adjuvant Chemotherapy in Colorectal Cancer: A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences, 24(12), 10230.
https://doi.org/10.3390/ijms241210230
